Industry Analysis Reports | Health Care | Medical Devices

Wednesday, 14 July 2021

Breast Imaging Market Overview, Trends, Global Demand By 2027

Market Overview

Global Breast Imaging Market is slated to register 7.5% CAGR during the review period, 2019 to 2025, and is projected to reach USD 4.9 billion in 2025.

Market Dynamics

Breast cancer's high prevalence rates around the world are major drivers of the global breast imaging technologies market. Furthermore, with rapid population growth and technological advancements in breast imaging technologies, early detection of breast cancer in developing countries, increased public investment, and fundraising for breast cancer treatment have led to the development of global breast imaging. The market's growth has been aided by rising healthcare expenditures in developed countries, as well as technological advancements in the field of oncology around the world. Furthermore, the introduction of new imaging technologies for the screening and diagnosis of a variety of chronic diseases has had a significant impact on market growth. Several companies engage in corporate social responsibility activities to educate women about breast health and prevention. Companies such as GE Healthcare, for example, have recently released a commercial raising awareness of breast density and its impact on screening techniques. During the appraisal period, demand for breast imaging is expected to rise due to increased awareness. Several major manufacturers are working on the development of innovative breast imaging equipment, which is expected to drive the global market over the forecast period.

Factors such as strict regulatory policies, product recalls, and others, on the other hand, are impeding the global market's growth. Furthermore, most women are apprehensive about having their breasts imaged due to a variety of misconceptions about the disease. This is thought to limit market growth in the coming years.

Segmental Analysis

The global breast imaging market is segmented based on technology, end users, and region.

The global market for breast imaging, by technology, is segmented into ionizing, non-ionizing, and others. The ionizing segment accounted for the largest segment of the market due to a high number of individuals opting for mammography.

Based on end user, the global market is segmented into hospitals and clinics, specialty centers, and others. The hospitals and clinics segment is expected to hold the largest market share.

Regional Analysis

The breast imaging market is divided into four regions: America, Asia Pacific, Europe, and the Middle East and Africa.

The United States is the largest market for breast imaging among all regions. The rising prevalence of breast cancer, innovative imaging solutions for breast imaging, and the development of new imaging devices by major market players are all contributing to the growth. Because of the high level of awareness of breast issues and the availability of appropriate health care facilities in the region, North America dominates the breast imaging market in terms of revenue. The widespread use of imaging modalities such as CT, mammography, and MRI for breast cancer screening is driving the market in North America. Because of the presence of major players and a focus on women's healthcare, the United States is thought to have the largest market share.

The European market is expected to grow significantly as a result of increased spending on research and development by major countries such as the United Kingdom. Europe, which has the second-highest revenue share in the global breast imaging technologies market, is experiencing rapid growth due to high health-care costs and high government disposable income. Due to widespread use of available imaging technologies for breast imaging, as well as the exponential growth of the medical device industry, the market in Germany is growing at a rapid pace. In addition, the desire to develop new imaging devices for early cancer screening is expected to drive market growth in this region.

Due to the presence of some of the largest contributors, such as China, Japan, and India, the Asia Pacific region offers numerous growth opportunities. The breast imaging market is expected to grow in this region as awareness of breast cancer grows, as does the use of medical devices for cancer screening. Furthermore, the rapid growth of the healthcare imaging industry in China and India, as well as rising government support for diagnostic services and healthcare infrastructure improvements, all contribute to market growth.

Competitive Analysis

Some of the key players operating in the global breast imaging market are Koninklijke Philips N.V. (Netherlands), GENERAL ELECTRIC COMPANY (US), Siemens Healthcare Private Limited (Germany), FUJIFILM Corporation (Japan), Hologic, Inc. (US), Dilon Technologies, Inc. (US), SonoCiné (US), CMR Naviscan (US), Supersonic Imagine (France), PLANMED OY (Finland), and KUB Technologies (US).

Related Reports:

Biosimilars Market Size

Tracheostomy products Market

Fertility Services Market

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Thursday, 8 July 2021

Dental Industry Market Demand to Forecast till 2027

Dental Industry Market Analysis

The global dental market is likely to grow at a 7.6% CAGR between 2018- 2023, as per the new report by Market Research Future (MRFR). The dental market comprises instruments, devices, treatment, and diagnosis associated with oral health. There are numerous problems related to oral health like discoloration or brown color in teeth, teeth cavity, pigmentation in gums, and others that are treated under the dental market.

Latest Free Sample Copy Available @ https://www.marketresearchfuture.com/sample_request/7637

Various factors are adding to the global dental market growth. Such factors, according to the new MRFR report, include rising geriatric population, the inclusion of 3D technology, increasing per capita income, better technological support, and rising cases of oral disease. Besides, demand for various dental procedures, rising prevalence of gum disease and oral cavity cancer & gum diseases, rise in technology, increasing awareness about oral health, consumers rising disposable income, changing lifestyles, and participation of health insurer reimbursements are also adding market growth.

On the contrary, low dental insurance coverage may limit the dental market growth over the forecast period.

Dental Industry Market Segmentation

The MRFR report offers an inclusive segmental analysis of the global dental market report based on end users, discipline, and consumables.

By discipline, the global dental market is segmented into oral surgery, prosthodontics, orthodontics, restorative dentistry, endodontics, and periodontics.

By consumables, the dental market is segmented into endodontic supplies, dental anesthetic, dental syringe, dental biomaterial, gingival retraction material, dental burs, and whitening material. Dental biomaterial is again segmented into regenerative tissue material, dental cement, and dental bone graft. Gingival retraction material is again segmented into gingival retraction cap/gels/paste, gingival hemostatic agents, and gingival retraction cord. Dental anesthetic is again segmented into non-injectable anesthetic, topical anesthetics, and injectable anesthetic. Dental syringe is again segmented into non-disposable syringes and safety syringes/disposable syringes. Endodontic supplies are again segmented into cement and files.

By end user, the dental market is segmented into research institutes, dental hospitals and clinics, and dental institutes and dental academics.

Dental Industry Market Regional Analysis

Based on the region, the dental products market size report covers the recent trends & growth opportunities across the Americas, Europe, the Asia Pacific (APAC), and the Middle East and Africa (MEA). Of these, the Americas will dominate the market over the forecast period for a huge patient pool having different oral issues, presence of several market players, and demand for cosmetic surgery. Additional factors adding market growth include easy inclusion of technologies, infrastructural backing, and better scope for investment. Canada & the US are the chief contributors in the region for the rising number of patients needing help from dentists.

The dental market in Europe is predicted to hold the second-largest share over the forecast period. Factors adding to the dental market growth in the region include gum problems, increasing tobacco consumption, and rising geriatric population. Besides, technological inclusion, better investment capacity, and Hungary being the dental tourism hub are also adding market growth.

The dental market in the APAC region is predicted to grow at the fastest pace over the forecast period for the changes in infrastructure and rising investments in the healthcare sector. Australia, Japan, India, and China are the chief contributors in the region.

The dental market in the MEA is predicted to have slow growth over the forecast period for the presence of countries that are economically poor.

Dental Industry Competitive Landscape

Leading players profiled in the global dental market report include Biomet, Zimmer Kangda Medical, 3M Company, Ultradent Products Inc., Young Innovations Inc., Patterson Companies Inc., Dentsply Sirona, Ivoclar Vivadent AG, Nakanishi Inc., Henry Schein Inc., and Hu-Friedy Mfg Co. Industry players have incorporated several strategies to stay ahead in the competition, such as geographic locations, mergers and acquisitions, expansions, joint ventures and collaborations, new product launch and development, contracts, and extensive R&D.

OBTAIN RESEARCH REPORT DETAILS WITH TOC @ https://www.marketresearchfuture.com/reports/dental-industry-market-7637

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Morphine (oral route) market size by top companies, demand and forecast

Medical Morphine Market synopsis:

Morphine is a pain medication which directly acts on the central nervous system to decrease acute and chronic pain. As per the report published by Market Research Future (MRFR), the global medical morphine market is anticipated to expand at a noteworthy CAGR of 7.5% during the forecast period of 2018-2023.

Latest Free Sample Copy Available @ https://www.marketresearchfuture.com/sample_request/6084

Medical Morphine Market Drivers:

Morphine is a quintessential pain medication which is prescribed by licensed medical practitioners to the patients with acute or chronic pain. The increased use of morphine by the patients suffering from cancer, arthritis, myocardial infarction and other diseases is driving the expansion of the global medical morphine market. Increasing geriatric population and prevalence of diseases like arthritis, cancer and others are inducing demand for morphine in the market, leading to the growth of the global medical morphine market.

The application of medical morphine as a slow-release formulation for opiate substitution therapy (OST) in various countries such as Austria, Slovenia and others is fueling the growth of the global medical morphine market. The benefits of morphine in reducing the shortness of breath due to cancerous and non-cancerous causes is also impacting positively on the expansion of the global medical morphine market.

Market Restraints:

However, the increased awareness regarding the adverse effects of morphine on the human body such as constipation, hormonal imbalance, drowsiness, functional impairment and others are negatively impacting the growth of the global medical morphine market. The stringent regulatory framework imposed by the government to limit the amount of morphine to be prescribed owing to the high abuse rate of morphine is acting as a restraint on the expansion of the global medical morphine market.

Market Segmentation:

The global morphine (oral Route) market has been segmented on the basis of route of administration, application, distribution channel and end-users. Based on route of administration, the medical morphine market is segmented into oral and injectable. Based on application, the medical morphine Market is segmented into arthritis, cancer, kidney stone, myocardial infarction, diarrhea and others. Based on distribution channel, the medical morphine market is segmented into hospital pharmacy, retail pharmacy, online pharmacy and others. Based on end-users, the medical morphine market is segmented into hospitals and clinics, ambulatory surgical centers, homecare, and others.

Regional Analysis:

The global medical morphine market is geographically segmented into four major regions such as Americas, Asia Pacific, Europe, and the Middle East and Africa. The Americas account for the largest market share in the global medical morphine market owing to the increasing demand for opioid drugs as pain relievers.

The Europe region accounts for the second largest market share in the global medical morphine market owing to the increasing prevalence of diseases like cancer, myocardial infarction and others. The medical morphine market in the Asia Pacific region is projecting noteworthy growth due to the increasing geriatric population and rise in use of medical morphine as pain medication in this region.

The Middle East and Africa region is anticipated to project steady growth in the global medical morphine market due to the limited availability of medical facilities, poor healthcare infrastructure, and lack of awareness among the population in underdeveloped areas of this region.

Competitive Analysis:

The increasing number of investors in the global medical morphine market is strengthening the competition among the players of the global medical morphine market. The high research and development expenditure by the pharmaceutical industries in order to launch new products in the global market and strategic mergers and acquisition by the players in the market is leading to the expansion of their businesses in the global medical morphine market.

In July 2018, Aurobindo Pharma, an Indian pharmaceutical company has announced that it is in its final stage of negotiation to acquire Mallinckrodt’s specialty generics business in the US including its portfolio of opioid-based painkillers such as morphine. This is considered to be the largest cross-border acquisition by an Indian pharmaceutical company in the recent times.

The key players of the global medical morphine market that are highlighted in the report published by MRFR are Mallinckrodt Pharmaceuticals, Alcaliber S.A, Purdue Pharma L.P., Pfizer Inc., Johnson Matthey Fine Chemicals, Sun Pharmaceutical Industries Ltd., Verve Health Care Ltd., Taj Pharmaceuticals Limited, NORTHEAST PHARM, and MANUS AKTTEVA BIOPHARMA LLP.

Browse Complete Report @ https://www.marketresearchfuture.com/reports/medical-morphine-market-6084

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Bone pain treatment market global Demand and Regional Forecast

Market Highlights

The global Osteomyelitis Market is expected to register an approximate CAGR of 6.1% during the forecast period.

The increasing prevalence of osteomyelitis, growing child population, and growing cases of diabetes are estimated to drive the market during the forecast period. However, factors such as the limited availability of treatments, risks associated with surgery, and low healthcare expenditure in the middle and low-income countries are estimated to restraint the market growth, during the forecast period.

Request Free Sample Copy Available @ https://www.marketresearchfuture.com/sample_request/6042

Segmentation

The global Bone pain treatment market is segmented on the basis of pathogenesis, diagnosis and treatment, and end-user.

The market for osteomyelitis is segmented by pathogenesis which is sub-segmented into trauma, contiguous spread, and others. By diagnosis, the market is categorized into physical examination, blood tests, imaging tests, bone biopsy, and others. The blood tests segment is sub-segmented into Complete Blood Count (CBC), Erythrocyte Sedimentation Rate (ESR), and C-Reactive Protein (CRP). The imaging segment is sub-segmented into X-rays, Computerized Tomography (CT) scan, and Magnetic Resonance Imaging (MRI). By treatment, the market is segmented into antibiotics and surgery. The antibiotics segment is sub-segmented into ceftriaxone, nafcillin, ceftazidime, and others. By end-user, the market is segmented into hospitals and clinics, research organizations, diagnostic diseases, and others.

Regional Analysis

The Americas dominates the global market for osteomyelitis. Huge patient population, high per capita income, the presence of market players, and developed economies such as the U.S. and Canada within the region provide favorable backgrounds for market growth. Europe is second in the market owing to the increasing acceptance of therapeutic surgeries, the presence of a developed healthcare sector, and rising reported cases of diabetes within the region. Asia Pacific is estimated to be the fastest growing region for the global osteomyelitis market owing to the increasing prevalence of diabetes, rising medical tourism, and an expanding healthcare sector within the region. The Middle East and Africa holds the least share in the global osteomyelitis market owing to the presence of poor economies, stringent government policies, and low per capita income, especially within the African region.

Key Players

Some of the key players for the global osteomyelitis market are Allergan Plc (Republic of Ireland) CrystalGenomics Inc (South Korea), Debiopharm International SA (Lausanne), Motif Bio Plc (London), Nabriva Therapeutics AG (Dublin), Vyome Biosciences Pvt Ltd (India), F. Hoffmann-La Roche AG (Switzerland), Koninklijke Philips N.V. (Netherlands), General Healthcare (U.S.), Siemens AG (Germany), Toshiba Corporation (Japan), Shimadzu Corporation (Japan), Samsung Electronics Co., Ltd. (South Korea), Neusoft Medical Systems Co., Ltd. (China), Medtronic plc (Ireland), Shenzhen Anke High-tech Co., Ltd. (Hong Kong), and others.

TABLE OF CONTENT

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power Of Suppliers

5.1.2 Bargaining Power Of Buyers

5.1.3 Threat Of New Entrants

5.1.4 Threat Of Substitutes

5.1.5 Intensity Of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Osteomyelitis Market, By Diagnosis And Treatment

6.1 Introduction

6.2 Diagnosis And Treatment

Market Estimates & Forecast, 2018–2023

6.2.1 Physical Examination

Market Estimates & Forecast, 2018–2023

6.2.2 Blood Tests

Market Estimates & Forecast, 2018–2023

6.2.2.1 Complete Blood Count (CBC)

6.2.2.2 Erythrocyte Sedimentation Rate (ESR)

6.2.2.3 C-Reactive Protein (CRP)

6.2.3 Imaging Tests

Market Estimates & Forecast, 2018–2023

6.2.3.1 X-Rays

6.2.3.2 Computerized Tomography (CT) Scan

6.2.3.3 Magnetic Resonance Imaging (MRI)

6.2.3.4 Others

6.2.4 Bone Biopsy

6.2.5 Others

6.3 Treatment

Market Estimates & Forecast, 2018–2023

6.3.1 Antibiotics

Market Estimates & Forecast, 2018–2023

6.3.1.1 Ceftriaxone

6.3.1.2 Nafcillin

6.3.1.3 Ceftazidime

6.3.1.4 Others

6.3.2 Surgery

Market Estimates & Forecast, 2018–2023

Chapter 7. Global Osteomyelitis Market, By Pathogenesis

Market Estimates & Forecast, 2018–2023

7.3.1 Trauma

7.3.2 Contiguous Spread

7.3.3 Others

Chapter 8. Global Osteomyelitis Market, By End-User

8.1 Introduction

8.2 Hospital And Clinics

Market Estimates & Forecast, 2018–2023

8.3 Research Organization

Market Estimates & Forecast, 2018–2023

8.4 Diagnostic Centers

Market Estimates & Forecast, 2018–2023

8.5 Others

Chapter 9. Global Osteomyelitis Market, By Region

Continued…
Obtain Complete Research Report with Toc, Graph and Figure @

https://www.marketresearchfuture.com/reports/osteomyelitis-market-6042

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Blog: https://healthcarenews12.blogspot.com/

Wednesday, 7 July 2021

Analysis on Veterinary Computed Tomography Scanner Market Size, Share and Trends by 2027

The global veterinary CT scanner market is expected to rise at a strong 6.2% CAGR over the forecast period from 2019 to 2025, according to the latest research report from Market Research Future (MRFR). The market was valued at a paltry USD 138.1 million in 2018, but is likely to grow at a rapid rate over the forecast period due to the increasing awareness about pet health and the use of CT scanners in ensuring and maintaining pet health. The report also contains a detailed analysis with regard to the COVID-19 pandemic, and states how the pandemic is likely to affect the market in the short and long term. The report also presents a detailed analysis of the market with respect to the major drivers and restraints affecting the global veterinary CT scanner market and the leading players operating in the global market.

Free Sample Copy of With Considering Coivd19 Impact on this Market @ https://www.marketresearchfuture.com/sample_request/5984

Veterinary CT scanners are equipment used to diagnose anomalies and diseases in animals specifically. Veterinary CT scanners can be used to diagnose cancers, cardiovascular diseases, trauma, and musculoskeletal disorders, among others, in pets and other domestic animals. The growing prevalence of cancer in pet animals is a major driver for the global veterinary CT scanner market and is likely to drive the market at a steady rate over the forecast period. Growing awareness among pet owners about animal cancer is also a major driver for the global veterinary CT scanner market, as this has driven the number of diagnostic tests for cancer. The increasing usage of advanced medical equipment for diagnosing problems in pet animals is likely to be a major driver for the global veterinary CT scanner market over the forecast period.

The increasing number of pets being adopted all over the world is likely to be a major driver for the global veterinary CT scanner market over the forecast period. According to the American Society for the Prevention of Cruelty to Animals, around 3.2 million shelter animals are adopted each year. This high number has led to growing prospects for the veterinary CT scanner market, as the number of pets under care in the developed world has grown rapidly. Increasing awareness about pet health and increasing readiness among pet owners to carry out investigative procedures to diagnose diseases in their pet animals is also a major driver for the global veterinary CT scanner market over the forecast period.

Veterinary CT Scanner Market- Competitive Leaderboard:

Leading players in the global Veterinary Computed Tomography Scanner Market include GNI ApS, Animage LLC, Hitachi Ltd., Samsung Electronics Co. Ltd., Siemens AG, Epica International Inc., Canon Inc., SOUND, GE Healthcare, and Koninklijke Philips NV. Major players in the global veterinary CT scanner market are likely to engage in merger and acquisition activity to increase their share in the global market. Strategic collaborations are also likely to be popular among players in the global veterinary CT scanner market over the forecast period.

Veterinary CT Scanner Market- Segmentation:

The global veterinary CT scanner market is segmented on the basis of type, slice, animal type, application, end use, and region.

By type, the global veterinary CT scanner market is segmented into stationary multi-slice CT scanners and portable CT scanners. The stationary multi-slice CT scanners segment is expected to dominate the global veterinary CT scanner market over the forecast period due to the enhanced functionality of stationary CT scanners in comparison to portable ones, which sacrifice some functionality in order to gain more convenience. The increasing use of stationary CT scanners in large hospitals and clinics is the major driver for the stationary multi-slice CT scanner segment over the forecast period.

By slice, the global veterinary CT scanner market is segmented into 4 slice, 8 slice, 16 slice, 32 slice, and 64 slice.

By animal type, the global veterinary CT scanner market is segmented into small and large animals.

By application, the global veterinary CT scanner market is segmented into cancer, cardiovascular diseases, infectious diseases, appendicitis, trauma, musculoskeletal disorders, and others.

By end use, the global veterinary CT scanner market is segmented into veterinary clinics, veterinary hospitals, and academic institutes.

Veterinary CT Scanner Market - Regional Analysis:

The Americas dominate the global veterinary CT scanner market, followed by Europe.

Global Veterinary CT Scanner Market, by Region

Americas

North America

US
Canada

Latin America

Europe

Western Europe

Germany
France
Italy
Spain
UK
Rest of Western Europe

Eastern Europe

Asia-Pacific

Japan
China
India
Australia
South Korea
Rest of Asia-Pacific

Middle East & Africa

Middle East
Africa

OBTAIN RESEARCH REPORT DETAILS WITH TOC @ https://www.marketresearchfuture.com/reports/veterinary-ct-scanner-market-5984

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Tuesday, 6 July 2021

Non-destructive medical technologies Market 2021- Global Demand, Key Players, Opportunity Assessment,

Market Highlights

Emergence of next-generation non-destructive technologies including X-ray computed tomography, and phased array ultrasonic are expected to replace the traditional technologies, which will offer prominent opportunities for the development of non-destructive technologies market growth during 2017-2023. Now a days, these technologies are used for the detection of thyroid, breast, lung, and ovary cancer. Cancer is one of the major problem across the globe and there is continuous development in the diagnostic and treatment method of cancer. With the help of advanced sensors & semiconductors, and technologies, a new instrument named as MasSpec Pen was designed, & built by researchers at the University of Texas at Austin. Introduction of MasSpec Pen has modernize the detection of cancer. During the clinical trials, MasSpec Pen has proven accurate in over 96 percent of test cases.

Increasing prevalence of cancer, rising need for better diagnostic treatment, increasing investment of biotechnology and pharmaceutical industries in R&D, and availability of funds drives the growth of the market. Moreover, increasing government support for research & development, changing lifestyle, and rapid development in technology fuels the market growth during the forecast period. However, long approval time, and high cost of the devices may slow the market growth during the forecasted period.

The global non-destructive testing market is expected to grow at a CAGR of ~ 10.8 % during the forecast period 2017-2023.

Regional Analysis

The Americas dominates the global non-destructive medical technologies market owing to the presence of huge patient with cancer, high healthcare spending, and increasing government support for research & development. Europe holds the second largest share of the global non-destructive medical technologies market followed by Asia Pacific. Asia Pacific is the fastest growing non-destructive medical technologies market. Japan holds the major share of the regional market due to availability of technology and huge healthcare spending. Rapidly developing economy, increasing healthcare expenditure, and government initiatives for research & development will drive the market in China and India during the forecasted period. The Middle East & Africa holds the least share of the global market due to limited availability of medical facilities. The UAE, Saudi Arabia, and Kuwait are expected to drive the Middle East & African market. Whereas, the African region is expected to witness a moderate growth.

Segmentation

The global non-destructive medical technologies market has been segmented on the basis of methods, application, products, and end user.

On the basis of methods, the market is segmented into echocardiography, medical ultrasonography, liquid penetrant, phased array ultrasonic testing, and digital radiography.

On the basis of equipment, the market is segmented into ultrasonic equipment, X-ray equipment, infra-red devices, and mass spectrometer.

On the basis of application, the market is segmented into diagnosis, and treatment.

On the basis of end user, the market is segmented into pharmaceutical & biotechnological companies, forensic laboratories, research organizations, and others.

Key Players

Some of key the players in the market are Eberlin Lab (US), Carestream Health (US), General Electric Company (US), Olympus Corporation (Japan), Element Materials Technology (US), Fischer Technology Inc. (US),Magnaflux Corporation (US), Sonotron NDT (Israel), Zetec Inc. (US), Sonatest Ltd. (UK), and Eddyfi NDT Inc. (Canada).

Access Report Details @ https://www.marketresearchfuture.com/reports/non-destructive-medical-technologies-market-4396

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Industry Analysis Reports | Health Care | Medical Devices | Pharmaceutical

Labels

Wednesday, 14 July 2021

Top Companies Demand on eClinical Solutions Market Size to Forecast by 2027

Breast Imaging Market Overview, Trends, Global Demand By 2027

Thursday, 8 July 2021

Dental Industry Market Demand to Forecast till 2027

Morphine (oral route) market size by top companies, demand and forecast

Bone pain treatment market global Demand and Regional Forecast

Wednesday, 7 July 2021

Analysis on Veterinary Computed Tomography Scanner Market Size, Share and Trends by 2027

Tuesday, 6 July 2021

Non-destructive medical technologies Market 2021- Global Demand, Key Players, Opportunity Assessment,

Blog Archive

Total Pageviews